End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.3 MYR | +1.54% | +4.43% | +4.76% |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 534 | 521.7 | 383.4 | 514.9 | 527.2 | 493 |
Enterprise Value (EV) 1 | 360 | 322.2 | 185.7 | 282.2 | 230.3 | 114.4 |
P/E ratio | 16.2 x | 24.3 x | 12 x | 13.8 x | 5.58 x | 14.8 x |
Yield | 1.28% | 1.31% | 1.79% | 1.33% | 1.3% | 1.39% |
Capitalization / Revenue | 0.7 x | 0.86 x | 0.58 x | 0.69 x | 0.45 x | 0.45 x |
EV / Revenue | 0.47 x | 0.53 x | 0.28 x | 0.38 x | 0.19 x | 0.1 x |
EV / EBITDA | 5.74 x | 5.94 x | 2.73 x | 3.46 x | 1.33 x | 1.16 x |
EV / FCF | 16 x | 17.8 x | 16.8 x | 13.2 x | 5.8 x | 1.26 x |
FCF Yield | 6.24% | 5.61% | 5.97% | 7.56% | 17.2% | 79.3% |
Price to Book | 0.91 x | 0.87 x | 0.65 x | 0.81 x | 0.72 x | 0.65 x |
Nbr of stocks (in thousands) | 136,934 | 136,934 | 136,934 | 136,934 | 136,934 | 136,934 |
Reference price 2 | 3.900 | 3.810 | 2.800 | 3.760 | 3.850 | 3.600 |
Announcement Date | 7/30/18 | 7/31/19 | 8/25/20 | 7/29/21 | 7/29/22 | 7/28/23 |
Income Statement Evolution (Annual data)
Fiscal Period: März | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 763.1 | 603.8 | 666.1 | 745.9 | 1,181 | 1,107 |
EBITDA 1 | 62.69 | 54.28 | 67.97 | 81.48 | 172.7 | 98.57 |
EBIT 1 | 47.02 | 38.52 | 49.4 | 60.92 | 150.6 | 75.7 |
Operating Margin | 6.16% | 6.38% | 7.42% | 8.17% | 12.75% | 6.84% |
Earnings before Tax (EBT) 1 | 51.39 | 38.57 | 48.74 | 60.34 | 149.9 | 74.91 |
Net income 1 | 32.94 | 21.48 | 32 | 37.36 | 94.42 | 33.29 |
Net margin | 4.32% | 3.56% | 4.8% | 5.01% | 8% | 3.01% |
EPS 2 | 0.2405 | 0.1569 | 0.2337 | 0.2728 | 0.6895 | 0.2431 |
Free Cash Flow 1 | 22.46 | 18.08 | 11.08 | 21.32 | 39.72 | 90.74 |
FCF margin | 2.94% | 2.99% | 1.66% | 2.86% | 3.36% | 8.2% |
FCF Conversion (EBITDA) | 35.83% | 33.3% | 16.3% | 26.17% | 23% | 92.05% |
FCF Conversion (Net income) | 68.19% | 84.14% | 34.62% | 57.08% | 42.06% | 272.55% |
Dividend per Share 2 | 0.0500 | 0.0500 | 0.0500 | 0.0500 | 0.0500 | 0.0500 |
Announcement Date | 7/30/18 | 7/31/19 | 8/25/20 | 7/29/21 | 7/29/22 | 7/28/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 174 | 200 | 198 | 233 | 297 | 379 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 22.5 | 18.1 | 11.1 | 21.3 | 39.7 | 90.7 |
ROE (net income / shareholders' equity) | 5.92% | 3.94% | 6.01% | 7.03% | 15.4% | 6.37% |
ROA (Net income/ Total Assets) | 4.14% | 3.32% | 4.23% | 4.97% | 10.6% | 4.87% |
Assets 1 | 796.4 | 646.4 | 756 | 752.4 | 892.3 | 683 |
Book Value Per Share 2 | 4.280 | 4.390 | 4.340 | 4.660 | 5.310 | 5.510 |
Cash Flow per Share 2 | 1.270 | 1.460 | 1.530 | 1.770 | 2.350 | 2.820 |
Capex 1 | 34.5 | 39 | 15.8 | 23 | 20.4 | 25.8 |
Capex / Sales | 4.51% | 6.45% | 2.38% | 3.08% | 1.73% | 2.33% |
Announcement Date | 7/30/18 | 7/31/19 | 8/25/20 | 7/29/21 | 7/29/22 | 7/28/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+4.76% | 94.77M | |
+5.14% | 103B | |
-5.63% | 63.04B | |
+39.52% | 39.06B | |
+12.91% | 37.58B | |
+7.41% | 33.24B | |
+6.85% | 19.22B | |
+12.86% | 16.83B | |
+7.73% | 15.03B | |
+16.93% | 14.96B |
- Stock Market
- Equities
- SAB Stock
- Financials Southern Acids (M)